Tumour markers for managing men who present with metastatic prostate cancer and serum prostate-specific antigen levels of <10 ng/mL

Specific Antigen ◽

Tumour Markers ◽

“PSA-itis”: Knowledge of Serum Prostate Specific Antigen and Other Causes of Anxiety in Men with Metastatic Prostate Cancer

10.1016/s0022-5347(05)64180-8 ◽

2002 ◽

Vol 168 (6) ◽

pp. 2516-2520 ◽

Cited By ~ 41

Author(s):

AISHA LOFTERS ◽

HELEN G. JUFFS ◽

GREGORY R. POND ◽

IAN F. TANNOCK

Keyword(s):

Prostate Cancer ◽

Specific Antigen ◽

Undetectable Serum Prostate-Specific Antigen Associated With Metastatic Prostate Cancer

American Journal of Clinical Oncology ◽

10.1097/00000421-199808000-00001 ◽

1998 ◽

Vol 21 (4) ◽

pp. 323-326 ◽

Cited By ~ 10

Author(s):

Afshin A. Safa ◽

David M. Reese ◽

Diane M. Carter ◽

Julia Phillipson ◽

Robert Smith ◽

...

Keyword(s):

Prostate Cancer ◽

Specific Antigen ◽

Undetectable Serum

???PSA-itis???: Knowledge of Serum Prostate Specific Antigen and Other Causes of Anxiety in Men with Metastatic Prostate Cancer

10.1097/00005392-200212000-00038 ◽

2002 ◽

pp. 2516-2520 ◽

Cited By ~ 3

Author(s):

AISHA LOFTERS ◽

HELEN G. JUFFS ◽

GREGORY R. POND ◽

IAN F. TANNOCK

Keyword(s):

Prostate Cancer ◽

Specific Antigen ◽

Integrating Circulating Tumor Cell Data with Imaging and Serum Prostate-Specific Antigen Measurement for Metastatic Prostate Cancer Therapy Management

Case Reports in Oncology ◽

10.1159/000361042 ◽

2014 ◽

Vol 7 (1) ◽

pp. 217-221

Author(s):

Oscar Goodman ◽

Eric R. Schuur

Keyword(s):

Prostate Cancer ◽

Cancer Therapy ◽

Tumor Cell ◽

Specific Antigen ◽

Circulating Tumor Cell ◽

Prostate Cancer Therapy ◽

Cell Data

Prognostic Significance of Changes in Short-Term Prostate Volume and Serum Prostate-Specific Antigen after Androgen Withdrawal in Men with Metastatic Prostate Cancer

Urologia Internationalis ◽

10.1159/000068769 ◽

2003 ◽

Vol 70 (3) ◽

pp. 195-199 ◽

Cited By ~ 7

Author(s):

Yuzo Furuya ◽

Osamu Nagakawa ◽

Hideki Fuse

Keyword(s):

Prostate Cancer ◽

Prostate Volume ◽

Prognostic Significance ◽

Specific Antigen ◽

Short Term ◽

Androgen Withdrawal

Metastatic prostate cancer with normal level of serum prostate-specific antigen

International Urology and Nephrology ◽

10.1023/b:urol.0000020306.08275.49 ◽

2003 ◽

Vol 35 (2) ◽

pp. 189-192 ◽

Cited By ~ 18

Author(s):

R. Nishio ◽

Y. Furuya ◽

O. Nagakawa ◽

H. Fuse

Keyword(s):

Prostate Cancer ◽

Normal Level ◽

Specific Antigen ◽

The Clinical Usefulness of Serum Prostate Specific Antigen After Hormonal Therapy of Metastatic Prostate Cancer

10.1016/s0022-5347(17)37432-3 ◽

1992 ◽

Vol 147 (3 Part 2) ◽

pp. 956-961 ◽

Cited By ~ 119

Author(s):

Jeffrey I. Miller ◽

Frederick R. Ahmann ◽

George W. Drach ◽

Scott S. Emerson ◽

Manfred R. Bottaccini

Keyword(s):

Prostate Cancer ◽

Hormonal Therapy ◽

Specific Antigen ◽

Clinical Usefulness ◽

Correlation of baseline serum testosterone (T) and serum prostate-specific antigen (PSA) at 7 months (7 mo PSA) in patients (pts) with new hormone sensitive metastatic prostate cancer (mHSPC) treated with continuous androgen deprivation therapy (cADT).

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e16019 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e16019-e16019

Author(s):

Shiven B. Patel ◽

Tyler Howard Buckley ◽

David Gill ◽

Srinivas Kiran Tantravahi ◽

Julia A. Batten ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Deprivation Therapy ◽

Specific Antigen ◽

Serum Testosterone ◽

Androgen Deprivation ◽

Baseline Serum ◽

Hormone Sensitive

1062: Bicalutamide 150 mg in Addition to Standard Care Significantly Improves Prostate Specific Antigen Progression-Free Survival in Patients with Early, Non-Metastatic Prostate Cancer: Median 5.4 Years' follow-up

10.1016/s0022-5347(18)38299-5 ◽

2004 ◽

Vol 171 (4S) ◽

pp. 280-281 ◽

Cited By ~ 2

Author(s):

William A. See ◽

Peter Iversen ◽

David G. McLeod ◽

Manfred P. Wirth ◽

Kevin Carroll ◽

...

Keyword(s):

Prostate Cancer ◽

Standard Care ◽

Specific Antigen ◽

Progression Free Survival ◽

Free Survival

Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliter

Urology ◽

10.1016/s0090-4295(02)01693-x ◽

2002 ◽

Vol 60 (4) ◽

pp. 31-35 ◽

Cited By ~ 55

Author(s):

Wolfgang Horninger ◽

Carol D Cheli ◽

Richard J Babaian ◽

Herbert A Fritsche ◽

Herbert Lepor ◽

...

Keyword(s):

Prostate Cancer ◽

Early Detection ◽

Specific Antigen ◽